J Korean Med Sci.  2023 Oct;38(41):e368. 10.3346/jkms.2023.38.e368.

Letter to the Editor: Frequency of Visual Aura in Non-Migraine Headache Strongly Depends on the Underlying Pathophysiology

• Finsterer J

• KMID: 2547181
• DOI: http://doi.org/10.3346/jkms.2023.38.e368

Reference

1. Kim SJ, Lee HJ, Lee SH, Cho S, Kim KM, Chu MK. Visual aura in non-migraine headaches: a population study. J Korean Med Sci. 2023; 38(31):e237. PMID: 37550805.

2. Wijeratne T, Wijeratne C, Korajkic N, Bird S, Sales C, Riederer F. Secondary headaches - red and green flags and their significance for diagnostics. eNeurologicalSci. 2023; 32:100473. PMID: 37456555.

3. Wade M. Medication-related visual hallucinations: what you need to know. Interviews with Fraunfelder FW, Jacobson J, Jun B. EyeNet magazine. Updated 2015. Accessed August 20, 2023. https://www.aao.org/eyenet/article/medication-related-visual-hallucinations-what-you-#:~:text=The%20medications%20most%20often%20associated,Fraunfelder%20said .

4. Jicha CJ, Alex A, Herskovitz S, Haut SR, Lipton R. Migraine with prolonged aphasic aura associated with a CACNA1A mutation: a case report and narrative review. Headache. 2023; 63(7):975–980. PMID: 37366229.

5. Kim DW, Lee SK. Headache and epilepsy. J Epilepsy Res. 2017; 7(1):7–15. PMID: 28775949.

6. Toom K, Raidvee A, Braschinsky M. The applicability of web-based solutions in headache epidemiology research. J Headache Pain. 2020; 21(1):60. PMID: 32487050.

7. Kim KM, Kim AR, Lee W, Jang BH, Heo K, Chu MK. Development and validation of a web-based headache diagnosis questionnaire. Sci Rep. 2022; 12(1):7032. PMID: 35488015.

8. Felício AC, Bichuetti DB, Santos WA, Godeiro Junior CO, Marin LF, Carvalho DS. Epidemiology of primary and secondary headaches in a Brazilian tertiary-care center. Arq Neuropsiquiatr. 2006; 64(1):41–44. PMID: 16622551.

9. Kim BK, Cho SJ, Kim BS, Sohn JH, Kim SK, Cha MJ, et al. Comprehensive application of the International Classification of Headache Disorders Third Edition, Beta Version. J Korean Med Sci. 2016; 31(1):106–113. PMID: 26770045.

10. Park S. An analysis and estimate of socioeconomic costs of narcotics and hazardous chemicals. J Police Policy. 2018; 32(3):217–253.

11. Hurkacz M, Dobrek L, Wiela-Hojeńska A. Antibiotics and the nervous system-which face of antibiotic therapy is real, Dr. Jekyll (neurotoxicity) or Mr. Hyde (neuroprotection)? Molecules. 2021; 26(24):7456. PMID: 34946536.

12. Viana M, Sances G, Linde M, Ghiotto N, Guaschino E, Allena M, et al. Clinical features of migraine aura: results from a prospective diary-aided study. Cephalalgia. 2017; 37(10):979–989. PMID: 27573009.

13. Kim KM, Kim BK, Lee W, Hwang H, Heo K, Chu MK. Prevalence and impact of visual aura in migraine and probable migraine: a population study. Sci Rep. 2022; 12(1):426. PMID: 35013446.

14. Kurth T, Rist PM, Ridker PM, Kotler G, Bubes V, Buring JE. Association of migraine with aura and other risk factors with incident cardiovascular disease in women. JAMA. 2020; 323(22):2281–2289. PMID: 32515815.

15. Kim BK, Cho S, Kim HY, Chu MK. Validity and reliability of the self-administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: a prospective clinic-based study. Headache. 2021; 61(6):863–871. PMID: 34106459.

16. Eriksen MK, Thomsen LL, Olesen J. The Visual Aura Rating Scale (VARS) for migraine aura diagnosis. Cephalalgia. 2005; 25(10):801–810. PMID: 16162257.

17. Kossoff EH, Andermann F. Migraine and epilepsy. Semin Pediatr Neurol. 2010; 17(2):117–122. PMID: 20541104.

18. Hartl E, Gonzalez-Victores JA, Rémi J, Schankin CJ, Noachtar S. Visual auras in epilepsy and migraine - an analysis of clinical characteristics. Headache. 2017; 57(6):908–916. PMID: 28488762.

19. Jeon JY, Lee H, Shin JY, Moon HJ, Lee SY, Kim JM, et al. Increasing trends in the incidence and prevalence of epilepsy in Korea. J Clin Neurol. 2021; 17(3):393–399. PMID: 34184447.